MedTrace Logo

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia

NCT05694962 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-01-25

No results posted yet for this study

Summary

This phase II trial studies low-dose radiation therapy as a treatment for patients with severe COVID-19 pneumonia to improve clinical status.

Conditions

Interventions

RADIATION

Low-Dose Radiation Therapy

1.5Gy single treatment of whole-lung radiation therapy

Sponsors & Collaborators

  • Nanjing Chest Hospital

    collaborator UNKNOWN

  • The Affiliated BenQ Hospital of Nanjing Medical University

    collaborator UNKNOWN

  • Central South University

    collaborator OTHER

  • Zhongda Hospital

    collaborator OTHER

  • Jiangsu Cancer Institute & Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694962 on ClinicalTrials.gov